These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2010-018604-85||Randomized study of yohimbine treatment for type 2 diabetes patients carrying a specific genetic risk variant||not-yet-due|
|Not reported||2011-000310-19||Fentanyl treatment in newborn infants: A Pharmacokinetic, Pharmacodynamic, and Pharmacogenetic Study (PK/PD model)||2019-02-05||due-trials|
|Ongoing||2012-005660-98||Effect of a single oral dose DPP-4 inhibitor sitagliptin on islet function after intake of a standardized mixed meal in patients with type 2 diabetes||not-yet-due|
|Ongoing||2013-005570-22||Comparison of three DPP-4 inhibitors on 24 hour blood glucose, incretin hormones and islet function in patients with type 2 diabetes||not-yet-due|
|Ongoing||2014-000871-17||Effects of Exenatid on Weigth during diet and Caloric Restriction in patients with Craniopharyngioma and Hypothalamic obesity||not-yet-due|
|Not reported||2014-002685-70||The Effect of Sitagliptin on Glucagon Dynamics and Incretin Hormones During Mild Hypoglycemia in Elderly Patients with Metformin-Treated Type 2 Diabetes||2017-03-14||due-trials|
|Ongoing||2014-005484-32||Double-blind, randomized placebo controlled study on the effect from cortisone treatment of vestibular neuritis - function, subjective well-being and stress||not-yet-due|
|Not reported||2015-001334-21||Study of the Effect of Vildagliptin versus Dapagliflozin on Glucagon Response to Mixed Meal in Metformin-treated Subjects with Type 2 Diabetes||2017-06-26||due-trials|
|Reported results||2016-005182-31||"An exploratory study regarding the use of the biomarker DAT for image diagnosis of clear cell renal cell carcinoma"||2018-09-12||due-trials|